NASDAQ:ALNY | ROE | ALNYLAM PHARMACEUTICALS, INC.

Complete source-backed roe history.

Available history
2008-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-3054.14%
2026-03-3146.16%
2025-12-3134.49%
2025-09-3032.85%
2025-06-30-51.47%
2025-03-31-54.08%
2024-12-31-414.62%
2024-09-30-1026.96%
2024-06-302378.25%
2024-03-31151.44%
2023-12-31199.53%
2023-09-30307.40%
2023-06-30260.59%
2023-03-31410.78%
2022-12-31714.91%
2022-09-301747.72%
2022-06-30-557.10%
2022-03-31-222.57%
2021-12-31-144.99%
2021-09-30-110.85%
2021-06-30-103.90%
2021-03-31-94.62%
2020-12-31-84.46%
2020-09-30-73.33%
2020-06-30-60.45%
2020-03-31-65.67%
2019-12-31-61.59%
2019-09-30-51.11%
2019-06-30-48.83%
2019-03-31-51.86%
2018-12-31-58.49%
2018-09-30-46.84%
2018-06-30-35.16%
2018-03-31-29.91%
2017-12-31-27.79%
2017-09-30-43.59%
2017-06-30-39.42%
2017-03-31-49.88%
2016-12-31-44.57%
2016-09-30-38.22%
2016-06-30-32.83%
2016-03-31-28.79%
2015-12-31-22.94%
2015-09-30-16.70%
2015-06-30-13.34%
2015-03-31-10.71%
2014-12-31-38.49%
2014-09-30-41.06%
2014-06-30-37.89%
2014-03-31-34.68%
2013-12-31-33.00%
2013-09-30-40.01%
2013-06-30-35.33%
2013-03-31-33.27%
2012-12-31-79.08%
2012-09-30-32.81%
2012-06-30-27.55%
2012-03-31-26.72%
2011-12-31-48.86%
2011-09-30-39.32%
2011-06-30-34.18%
2011-03-31-32.62%
2010-12-31-27.50%
2010-09-30-27.62%
2010-06-30-26.56%

Annual ROE

DateROE
2025-12-3139.76%
2024-12-31-414.62%
2023-12-31199.53%
2022-12-31714.91%
2021-12-31-144.99%
2020-12-31-84.46%
2019-12-31-61.59%
2018-12-31-58.49%
2017-12-31-27.79%
2016-12-31-44.57%
2015-12-31-22.94%
2014-12-31-38.49%
2013-12-31-33.00%
2012-12-31-79.08%
2011-12-31-48.86%
2010-12-31-27.50%
2009-12-31-26.74%
2008-12-31-12.99%